By Patrick Wingrove (Reuters) – Novo Nordisk said on Tuesday it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed. Novo said the trial would be halted almost a year early based on a recommendation...
Tag: <span>Novo Nordisk</span>
Post
Novo Nordisk Exec: Oral Weight-Loss Drug Will Have Similar Efficacy as Wegovy
May 05, 2023 COPENHAGEN/LONDON (Reuters) – Novo Nordisk expects the oral version of its semaglutide drug to treat obesity to have similar efficacy as its Wegovy injection, with data from a late-stage clinical trial due before the end of June, a senior executive said on Thursday. Head of development Martin Holst Lange was discussing the trial called...
Post
Novo Nordisk to cut insulin prices by up to 75% in 2024
Nicole DeFeudis Editor Novo Nordisk is cutting the price of its insulin products by up to 75%, the company announced on Tuesday. Beginning in January 2024, Novo Nordisk will slash the price of brand name NovoLog and NovoLog Mix 70/30 insulin products by 75%, and Novolin and Levemir products by 65%. A Novo Nordisk spokesperson...